Axxcess Wealth Management LLC Has $4.31 Million Stock Holdings in Colgate-Palmolive Company $CL

Axxcess Wealth Management LLC grew its stake in Colgate-Palmolive Company (NYSE:CL) by 0.4% during the second quarter, HoldingsChannel.com reports. The firm owned 47,377 shares of the company’s stock after buying an additional 206 shares during the period. Axxcess Wealth Management LLC’s holdings in Colgate-Palmolive were worth $4,306,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in CL. Westend Capital Management LLC lifted its stake in Colgate-Palmolive by 111.1% in the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 140 shares during the period. Cornerstone Planning Group LLC lifted its stake in Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after buying an additional 287 shares during the period. Saudi Central Bank acquired a new position in Colgate-Palmolive in the first quarter valued at about $29,000. Ransom Advisory Ltd acquired a new position in Colgate-Palmolive in the first quarter valued at about $33,000. Finally, Y.D. More Investments Ltd acquired a new position in Colgate-Palmolive in the first quarter valued at about $37,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.9%

NYSE:CL opened at $78.43 on Wednesday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The company has a market cap of $63.39 billion, a PE ratio of 22.03, a PEG ratio of 4.24 and a beta of 0.34. Colgate-Palmolive Company has a 52-week low of $76.68 and a 52-week high of $102.61. The stock has a 50-day simple moving average of $82.34 and a 200 day simple moving average of $87.67.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the company earned $0.91 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CL. Barclays cut their target price on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Piper Sandler started coverage on Colgate-Palmolive in a research note on Friday, October 3rd. They issued a “neutral” rating and a $84.00 target price on the stock. Morgan Stanley lowered their price target on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Finally, UBS Group lowered their price target on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.